Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint Infections.

Morata L, Cobo J, Fernández-Sampedro M, Guisado Vasco P, Ruano E, Lora-Tamayo J, Sánchez Somolinos M, González Ruano P, Rico Nieto A, Arnaiz A, Estébanez Muñoz M, Jiménez-Mejías ME, Lozano Serrano AB, Múñez E, Rodriguez-Pardo D, Argelich R, Arroyo A, Barbero JM, Cuadra F, Del Arco A, Del Toro MD, Guio L, Jimenez-Beatty D, Lois N, Martin O, Martínez Alvarez RM, Martinez-Marcos FJ, Porras L, Ramírez M, Vergas García J, Soriano A.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02280-18. doi: 10.1128/AAC.02280-18. Print 2019 May.

PMID:
30858217
2.

Effects of sardine-enriched diet on metabolic control, inflammation and gut microbiota in drug-naïve patients with type 2 diabetes: a pilot randomized trial.

Balfegó M, Canivell S, Hanzu FA, Sala-Vila A, Martínez-Medina M, Murillo S, Mur T, Ruano EG, Linares F, Porras N, Valladares S, Fontalba M, Roura E, Novials A, Hernández C, Aranda G, Sisó-Almirall A, Rojo-Martínez G, Simó R, Gomis R.

Lipids Health Dis. 2016 Apr 18;15:78. doi: 10.1186/s12944-016-0245-0.

3.

TALE-mediated epigenetic suppression of CDKN2A increases replication in human fibroblasts.

Bernstein DL, Le Lay JE, Ruano EG, Kaestner KH.

J Clin Invest. 2015 May;125(5):1998-2006. doi: 10.1172/JCI77321. Epub 2015 Apr 13.

4.

Altered clock gene expression in obese visceral adipose tissue is associated with metabolic syndrome.

Vieira E, Ruano Eg, Figueroa AL, Aranda G, Momblan D, Carmona F, Gomis R, Vidal J, Hanzu FA.

PLoS One. 2014 Nov 3;9(11):e111678. doi: 10.1371/journal.pone.0111678. eCollection 2014.

5.

Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls.

Canivell S, Rebuffat S, Ruano EG, Kostov B, Sisó-Almirall A, Novials A, Ceriello A, Gomis R.

Diabetes Metab Res Rev. 2015 Feb;31(2):212-9. doi: 10.1002/dmrr.2599. Epub 2014 Oct 21.

PMID:
25139699
6.

REV-ERB ALPHA polymorphism is associated with obesity in the Spanish obese male population.

Ruano EG, Canivell S, Vieira E.

PLoS One. 2014 Aug 4;9(8):e104065. doi: 10.1371/journal.pone.0104065. eCollection 2014.

7.

Differential methylation of TCF7L2 promoter in peripheral blood DNA in newly diagnosed, drug-naïve patients with type 2 diabetes.

Canivell S, Ruano EG, Sisó-Almirall A, Kostov B, González-de Paz L, Fernandez-Rebollo E, Hanzu FA, Párrizas M, Novials A, Gomis R.

PLoS One. 2014 Jun 10;9(6):e99310. doi: 10.1371/journal.pone.0099310. eCollection 2014.

8.

Gastric inhibitory polypeptide receptor methylation in newly diagnosed, drug-naïve patients with type 2 diabetes: a case-control study.

Canivell S, Ruano EG, Sisó-Almirall A, Kostov B, González-de Paz L, Fernandez-Rebollo E, Hanzu F, Párrizas M, Novials A, Gomis R.

PLoS One. 2013 Sep 23;8(9):e75474. doi: 10.1371/journal.pone.0075474. eCollection 2013.

9.

Intensity-dependent constitutional MLH1 promoter methylation leads to early onset of colorectal cancer by affecting both alleles.

Auclair J, Vaissière T, Desseigne F, Lasset C, Bonadona V, Giraud S, Saurin JC, Joly MO, Leroux D, Faivre L, Audoynaud C, Montmain G, Ruano E, Herceg Z, Puisieux A, Wang Q.

Genes Chromosomes Cancer. 2011 Mar;50(3):178-85. doi: 10.1002/gcc.20842. Epub 2010 Dec 9.

PMID:
21213371
10.

Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation.

Auclair J, Leroux D, Desseigne F, Lasset C, Saurin JC, Joly MO, Pinson S, Xu XL, Montmain G, Ruano E, Navarro C, Puisieux A, Wang Q.

Hum Mutat. 2007 Nov;28(11):1084-90.

PMID:
17557300
11.

Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing.

Auclair J, Busine MP, Navarro C, Ruano E, Montmain G, Desseigne F, Saurin JC, Lasset C, Bonadona V, Giraud S, Puisieux A, Wang Q.

Hum Mutat. 2006 Feb;27(2):145-54.

PMID:
16395668
12.

Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type.

Wang Q, Montmain G, Ruano E, Upadhyaya M, Dudley S, Liskay RM, Thibodeau SN, Puisieux A.

Hum Genet. 2003 Feb;112(2):117-23. Epub 2002 Nov 21.

PMID:
12522551
13.

Novel quinolinone-phosphonic acid AMPA antagonists devoid of nephrotoxicity.

Cordi AA, Desos P, Ruano E, Al-Badri H, Fugier C, Chapman AG, Meldrum BS, Thomas JY, Roger A, Lestage P.

Farmaco. 2002 Oct;57(10):787-802.

PMID:
12420874
14.

Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer.

Wang Q, Lasset C, Desseigne F, Saurin JC, Maugard C, Navarro C, Ruano E, Descos L, Trillet-Lenoir V, Bosset JF, Puisieux A.

Hum Genet. 1999 Jul-Aug;105(1-2):79-85.

PMID:
10480359
15.

Neurofibromatosis and early onset of cancers in hMLH1-deficient children.

Wang Q, Lasset C, Desseigne F, Frappaz D, Bergeron C, Navarro C, Ruano E, Puisieux A.

Cancer Res. 1999 Jan 15;59(2):294-7.

Supplemental Content

Support Center